These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38708719)
1. Human Serum Albumin Mediated Controllable Synthesis of Defect-Rich Copper Hydroxide Nanowire for Cuproptosis-Based Anti-Tumor Therapy. Man R; Xia M; Li H; Tian F; Zhang J; Yu Z; Tang B Adv Healthc Mater; 2024 Sep; 13(23):e2401078. PubMed ID: 38708719 [TBL] [Abstract][Full Text] [Related]
2. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy. Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515 [TBL] [Abstract][Full Text] [Related]
3. Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation. Zafar H; Zhang J; Raza F; Pan X; Hu Z; Feng H; Shen Q J Control Release; 2024 Aug; 372():446-466. PubMed ID: 38917953 [TBL] [Abstract][Full Text] [Related]
4. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261 [TBL] [Abstract][Full Text] [Related]
5. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152 [TBL] [Abstract][Full Text] [Related]
6. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy. Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475 [TBL] [Abstract][Full Text] [Related]
7. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869 [TBL] [Abstract][Full Text] [Related]
8. Self-Assembled Copper-Amino Acid Nanoparticles for in Situ Glutathione "AND" H Ma B; Wang S; Liu F; Zhang S; Duan J; Li Z; Kong Y; Sang Y; Liu H; Bu W; Li L J Am Chem Soc; 2019 Jan; 141(2):849-857. PubMed ID: 30541274 [TBL] [Abstract][Full Text] [Related]
9. Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response. Tang W; Wu J; Wang L; Wei K; Pei Z; Gong F; Chen L; Han Z; Yang Y; Dai Y; Cui X; Cheng L ACS Nano; 2024 Apr; 18(15):10495-10508. PubMed ID: 38556991 [TBL] [Abstract][Full Text] [Related]
10. DNAzyme-Mediated Cascade Nanoreactor for Cuproptosis-Promoted Pancreatic Cancer Synergistic Therapy. Yu Q; Zhou J; Liu Y; Li XQ; Li S; Zhou H; Kang B; Chen HY; Xu JJ Adv Healthc Mater; 2023 Nov; 12(28):e2301429. PubMed ID: 37548109 [TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy. Xu W; Wang Y; Hou G; Wang J; Wang T; Qian J; Suo A Adv Healthc Mater; 2023 May; 12(13):e2202949. PubMed ID: 36716523 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy. Li K; Wu L; Wang H; Fu Z; Gao J; Liu X; Fan Y; Qin X; Ni D; Wang J; Xie D J Nanobiotechnology; 2024 Sep; 22(1):546. PubMed ID: 39237931 [TBL] [Abstract][Full Text] [Related]
13. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy. Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859 [TBL] [Abstract][Full Text] [Related]
14. Redox Homeostasis Disruptors Based on Metal-Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and Cuproptosis. Zhao F; Yu H; Liang L; Wang C; Shi D; Zhang X; Ying Y; Cai W; Li W; Li J; Zheng J; Qiao L; Che S; Yu J Adv Healthc Mater; 2023 Nov; 12(29):e2301346. PubMed ID: 37369362 [TBL] [Abstract][Full Text] [Related]
15. Coordination Self-Assembled AuTPyP-Cu Metal-Organic Framework Nanosheets with pH/Ultrasound Dual-Responsiveness for Synergistically Triggering Cuproptosis-Augmented Chemotherapy. Bao J; Wang J; Chen S; Liu S; Wang Z; Zhang W; Zhao C; Sha Y; Yang X; Li Y; Zhong Y; Bai F ACS Nano; 2024 Mar; 18(12):9100-9113. PubMed ID: 38478044 [TBL] [Abstract][Full Text] [Related]
16. CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy. Bai J; Zhang X; Zhao Z; Sun S; Cheng W; Yu H; Chang X; Wang B Small; 2024 Oct; 20(40):e2400326. PubMed ID: 38813723 [TBL] [Abstract][Full Text] [Related]
17. Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells. Shen WY; Jia CP; Mo AN; Liang H; Chen ZF Eur J Med Chem; 2021 Nov; 223():113636. PubMed ID: 34175540 [TBL] [Abstract][Full Text] [Related]
18. Glutathione-Scavenging Celastrol-Cu Nanoparticles Induce Self-Amplified Cuproptosis for Augmented Cancer Immunotherapy. Lu S; Li Y; Yu Y Adv Mater; 2024 Aug; 36(35):e2404971. PubMed ID: 38935977 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of Copper Peroxide Nanodots for H Lin LS; Huang T; Song J; Ou XY; Wang Z; Deng H; Tian R; Liu Y; Wang JF; Liu Y; Yu G; Zhou Z; Wang S; Niu G; Yang HH; Chen X J Am Chem Soc; 2019 Jun; 141(25):9937-9945. PubMed ID: 31199131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]